Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-20

Study Completion Date

2031-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study

NCT03683004

Colorectal Cancer

COMPLETED

A Longitudinal Investigation of Cognitive Function in Colorectal Cancer Patients

NCT01457287

Colorectal Cancer

COMPLETED

Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy

NCT00188331

Cognition Fatigue Colorectal Neoplasm

COMPLETED

A Web-Based Dyadic Intervention for Colorectal Cancer

NCT05663203

Colorectal Carcinoma

RECRUITING NA

Confusion in the Elderly After Colon Surgery

NCT01623297

Confusion Inflammation Acute Phase Reaction +2 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasm, Colorectal Cognitive Impairment Cognitive Dysfunction Cognitive Change Chemo-brain Chemo Fog Chemotherapy Effect Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH)- Good Clinical Practice (GCP), the local regulatory requirements, and permission to use private health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) prior to study-specific screening procedures. Must be able to provide study-specific informed consent prior to study entry.
* A histologically-confirmed colorectal tumor
* Patients who will be treated with cytotoxic chemotherapies including Capecitabine, Oxaliplatin, 5 fluorouracil, and Irinotecan are eligible.
* Patients must not have received cytotoxic chemotherapy previous to enrollment.

Exclusion Criteria

* Prior administration of anti-cancer chemotherapy, radiotherapy, immunotherapy, or investigational agents
* Patients having mental incompetence as assessed by study PI, which would hinder completion of the surveys
* Pregnant or breastfeeding
* Any known brain metastases
* Non-English speaking patients
* Patients who have been diagnosed with any neuro-cognitive disorder including traumatic brain injuries, Alzheimer's disease, Parkinson's disease, Huntington's disease, and Creutzfeldt-Jakob disease.
* Patients deemed inappropriate to participate in this study by the study PI or coordinator will be excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No